Paratek Pharmaceuticals, Inc.
Symbol: PRTK
NASDAQ
2.23
USDDzisiejsza cena rynkowa
-3.0521
Wskaźnik P/E
0.1791
Wskaźnik PEG
127.83M
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Paratek Pharmaceuticals, Inc. (PRTK) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 178.97 | 34.2 | 95.5 | 125.2 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 190.45 | 78 | 33.1 | 15.7 | |||||||||||||||||||||
balance-sheet.row.inventory | 62.72 | 16.6 | 11 | 14.6 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 41.91 | 7.9 | 12.4 | 7.8 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 474.42 | 136.8 | 152.1 | 164.1 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8.63 | 2.4 | 2.6 | 3 | |||||||||||||||||||||
balance-sheet.row.goodwill | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 140.11 | 32.5 | 28.4 | 8.9 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 152.06 | 35.7 | 31.8 | 12.7 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 626.48 | 172.5 | 183.9 | 176.9 | |||||||||||||||||||||
balance-sheet.row.account-payables | 21.68 | 5.3 | 5.4 | 1.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 164.04 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 872.3 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 91.2 | 32.1 | 25.9 | 22.1 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1042.35 | 306.2 | 280.4 | 255.2 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4.89 | 1.5 | 1.3 | 1.5 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1354.08 | 343.6 | 311.7 | 279.1 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0.23 | 0.1 | 0.1 | 705.5 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | -3769.48 | -930.4 | -866.9 | -807.8 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.12 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3041.77 | 759.4 | 739.1 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 626.48 | 172.5 | 183.9 | 176.8 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 626.48 | - | - | - | |||||||||||||||||||||
Total Investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.total-debt | 1036.34 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
balance-sheet.row.net-debt | 887.3 | 224.2 | 175.4 | 146.9 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -62.73 | -63.6 | -59.1 | -96.5 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.31 | 0.5 | 0.4 | 0.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 1.1 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 10.34 | 12.3 | 14.3 | 10.2 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 23.96 | -20.8 | -8.2 | -20.3 | |||||||||||||||||||
cash-flows.row.account-receivables | -5.71 | -40.4 | -21.8 | -7.5 | |||||||||||||||||||
cash-flows.row.inventory | -2.05 | -9.1 | -15.5 | -11.8 | |||||||||||||||||||
cash-flows.row.account-payables | 8.96 | 7.7 | 6.8 | 1.6 | |||||||||||||||||||
cash-flows.row.other-working-capital | 22.76 | 21 | 22.3 | -2.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 4.91 | 5.4 | 4.3 | 1.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -23.22 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -15.16 | -15.2 | -15.1 | -29.6 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 30 | 30 | 20 | 122.5 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 15.2 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 29.97 | 14.8 | 4.5 | 92.5 | |||||||||||||||||||
cash-flows.row.debt-repayment | -3.73 | -2.9 | -0.3 | -70 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 7.3 | 18.4 | 21.9 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.other-financing-activites | -0.12 | 0.7 | 0.3 | 59.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.57 | 5.1 | 18.3 | 11.3 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 3.18 | -46.2 | -25.4 | 0.4 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 149.55 | 34.4 | 80.6 | 106 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 146.37 | 80.6 | 106 | 105.6 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -23.22 | -66.1 | -48.3 | -103.4 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -23.29 | -66.2 | -48.6 | -103.8 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 167.74 | 150.8 | 121 | 43.5 | ||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 25.3 | 23.1 | 21.5 | 8.7 | ||||||||||||||||||||||
income-statement-row.row.gross-profit | 142.45 | 127.7 | 99.4 | 34.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
income-statement-row.row.research-development | 38.83 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.operating-expenses | 186.99 | 173.9 | 140.5 | 110.4 | ||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 212.29 | 197 | 162.1 | 119 | ||||||||||||||||||||||
income-statement-row.row.interest-income | 0.99 | 0.8 | 0.1 | 1.5 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.95 | 1.3 | 0.4 | 1.6 | ||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -43.4 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.operating-income | -44.54 | -46.2 | -41.1 | -75.5 | ||||||||||||||||||||||
income-statement-row.row.income-before-tax | -62.56 | -63.5 | -58.5 | -96.5 | ||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 4.56 | 0.1 | 0.6 | 19.7 | ||||||||||||||||||||||
income-statement-row.row.net-income | -67.12 | -63.6 | -59.1 | -116.3 |
Często zadawane pytania
Ile wynosi Paratek Pharmaceuticals, Inc. (PRTK) aktywów ogółem?
Paratek Pharmaceuticals, Inc. (PRTK) całkowite aktywa to 172538000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 67270000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.850.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -0.190.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -0.299.
Jaki jest całkowity przychód firmy?
Całkowity przychód to -0.201.
Co to jest Paratek Pharmaceuticals, Inc. (PRTK) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -63566000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 258414000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 173941000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 42685000.000.